Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Cash from Financing Activities

Apellis Pharmaceuticals Inc Cash from Financing Activities Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Cash from Financing Activities from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Cash from Financing Activities for the quarter ending December 12, 2018 was $0m a -92.55% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Cash from Financing Activities for the last 12 months ending December 12, 2018 was $132m a -49.80% decrease of -66m year over year
  • Apellis Pharmaceuticals Inc Annual Cash from Financing Activities for 2018 was $132m a -49.64% decrease of -65m from 2017
  • Apellis Pharmaceuticals Inc Annual Cash from Financing Activities for 2017 was $197m a 92.47% increase of 183m from 2016
  • Apellis Pharmaceuticals Inc Annual Cash from Financing Activities for 2016 was $15m a -177.44% decrease of -26m from 2015
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
View Chart On Koyfin

Quarterly APLS Cash from Financing Activities Data

12/2018$0m
09/2018$0m
06/2018$132m
03/2018$0m
12/2017$178m
09/2017$19m

Annual APLS Cash from Financing Activities Data

2018$132m
2017$197m
2016$15m
2015$41m